As of 3:59pm ET
| +0.15 / +1.06%|
The 6 analysts offering 12-month price forecasts for Momenta Pharmaceuticals Inc have a median target of 14.50, with a high estimate of 19.00 and a low estimate of 10.00. The median estimate represents a +1.05% increase from the last price of 14.35.
The current consensus among 6 polled investment analysts is to Hold stock in Momenta Pharmaceuticals Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.